Laxmi Dental

Why is Laxmi Dental Ltd falling/rising?

As of 09-Aug, Laxmi Dental Ltd's stock price is at 216.70, down 0.8%, and has seen a decline over the last two days with reduced investor participation. Despite recent underperformance, the company is net-debt free and has strong long-term growth potential, indicating possible recovery ahead.

As of 09-Aug, Laxmi Dental Ltd's stock price is currently at 216.70, reflecting a decrease of 1.75 (-0.8%). The stock has been experiencing a downward trend, having fallen for the last two consecutive days, resulting in a total decline of -0.78% during this period. This decline is coupled with a significant drop in investor participation, as evidenced by a 51.92% decrease in delivery volume compared to the 5-day average.<BR><BR>In terms of performance relative to the market, the stock has shown a mixed picture. Over the past week, it has outperformed the Sensex with a return of +1.74% compared to the index's +0.52%. However, on a longer-term basis, the stock has underperformed significantly, with a year-to-date decline of -20.27% against the Sensex's -7.89%, and a staggering -45.93% drop over the past year.<BR><BR>Despite these negative trends, there are positive factors that could support the stock in the long run. The company is net-debt free and has reported healthy long-term growth, with an operating profit growth rate of 149.66%. Additionally, it has shown strong quarterly results, with net sales reaching their highest at Rs 73.95 crore and a notable operating profit margin.<BR><BR>Overall, while Laxmi Dental Ltd is currently facing a decline in stock price, the underlying fundamentals suggest potential for recovery, although recent performance and investor sentiment appear to be weighing heavily on the stock's current trajectory.

Which are the latest news on Laxmi Dental?

What does Laxmi Dental do?

Laxmi Dental Ltd is a small-cap healthcare services company that specializes in dental care, with net sales of 74 Cr and a net profit of 10 Cr as of March 2026. The company was incorporated in 2004 and became public in 2024.

Overview: <BR>Laxmi Dental Ltd operates in the healthcare services industry and is categorized as a small-cap company.<BR><BR>History: <BR>Laxmi Dental Limited was incorporated in 2004 as Laxmi Dental Export Private Limited. The company underwent a name change to Laxmi Dental Private Limited in June 2024 and subsequently converted to a public company as Laxmi Dental Limited in August 2024. The most recent quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 74 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 10 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 1,224 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 35.00 <BR>Industry P/E: 92 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.04 <BR>Return on Equity: 14.29% <BR>Price-to-Book: 5.14 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

How big is Laxmi Dental?

As of 10th June, Laxmi Dental Ltd has a market capitalization of 1,224.00 Cr, with recent Net Sales of 277.86 Cr and a Net Profit of 28.98 Cr. Shareholder's Funds are 208.54 Cr and Total Assets are valued at 278.22 Cr as of March 2025.

As of 10th June, Laxmi Dental Ltd has a market capitalization of 1,224.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Laxmi Dental reported Net Sales of 277.86 Cr and a Net Profit of 28.98 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, where Shareholder's Funds amounted to 208.54 Cr and Total Assets were valued at 278.22 Cr.

Who are the peers of the Laxmi Dental?

Laxmi Dental's peers include Suven Life Sciences, Vimta Labs, Krsnaa Diagnostics, Suraksha Diagnostics, Tarsons Products, One Global Services, 3B Blackbio, and Health X Platform. Laxmi Dental has average management risk and good growth, but its 1-year return of -48.44% is the lowest among its peers.

Peers: The peers of Laxmi Dental are Suven Life Scie., Vimta Labs, Krsnaa Diagnost., Suraksha Diagno., Tarsons Products, One Global Serv, 3B Blackbio, and Health X Platfor.<BR><BR>Quality Snapshot: Excellent management risk is observed at Vimta Labs, Krsnaa Diagnost., Suraksha Diagno., One Global Serv, and 3B Blackbio, while Average management risk is found at Laxmi Dental, Suven Life Scie., Krsnaa Diagnost., Tarsons Products, and Health X Platfor. Below Average management risk is noted at Suven Life Scie., Tarsons Products, and Health X Platfor. Growth is rated as Excellent for One Global Serv, Good for Laxmi Dental and Suraksha Diagno., and Below Average for Suven Life Scie., Vimta Labs, Krsnaa Diagnost., Tarsons Products, 3B Blackbio, and Health X Platfor. Capital Structure is Excellent for Laxmi Dental, Vimta Labs, Krsnaa Diagnost., One Global Serv, and 3B Blackbio, while Good is noted for Suraksha Diagno. and Tarsons Products, and Below Average for Suven Life Scie. and Health X Platfor.<BR><BR>Return Snapshot: One Global Serv has the highest 1-year return at 104.99%, while Laxmi Dental has the lowest at -48.44%. Laxmi Dental's 1-year return is significantly lower than all peers. Additionally, Suven Life Scie., Krsnaa Diagnost., Suraksha Diagno., Tarsons Products, 3B Blackbio, and Health X Platfor all have negative six-month returns.

Should I buy, sell or hold Laxmi Dental Ltd?

Are Laxmi Dental Ltd latest results good or bad?

Laxmi Dental Ltd's Q4 FY26 results show strong revenue growth of 21.89% year-on-year and a significant net profit increase of 409.09% quarter-on-quarter. However, concerns about margin volatility suggest investors should exercise caution and monitor future performance closely.

Laxmi Dental Ltd's latest results for Q4 FY26 present a mixed picture. On one hand, the company achieved a robust revenue of ₹73.95 crores, reflecting an 11.98% sequential increase and a significant 21.89% year-on-year growth. The net profit also saw a remarkable recovery, soaring by 409.09% quarter-on-quarter to ₹10.08 crores, indicating strong underlying demand and operational improvements.<BR><BR>However, there are notable concerns regarding margin volatility. The operating profit margin fluctuated dramatically from 10.87% in the previous quarter to 18.70% in Q4, raising questions about the sustainability of this profitability. Such swings in margins can indicate operational inconsistency, which investors should monitor closely.<BR><BR>Overall, while the headline numbers are impressive and suggest strong growth potential, the significant margin volatility and operational inconsistency warrant caution. Investors may want to wait for more consistent performance in upcoming quarters before making any decisions.

When is the next results date for Laxmi Dental Ltd?

The next results date for Laxmi Dental Ltd is 10 February 2026.

The next results date for Laxmi Dental Ltd is scheduled for 10 February 2026.

Is Laxmi Dental overvalued or undervalued?

As of December 4, 2025, Laxmi Dental is considered overvalued with a high PE ratio of 57.86 and other elevated valuation metrics, despite respectable returns on capital and equity, and has underperformed the Sensex recently.

As of 4 December 2025, Laxmi Dental has moved from a fair to an expensive valuation grade. The company is currently overvalued, as indicated by its high PE ratio of 57.86, a Price to Book Value of 6.75, and an EV to EBITDA of 36.56. In comparison to its peers, Laxmi Dental's valuation metrics are significantly higher, with Lenskart Solutions having a PE of 237.94 and Poly Medicure at 53.38, both categorized as very expensive.<BR><BR>The company's return on capital employed (ROCE) stands at 12.57% and return on equity (ROE) at 11.66%, which, while respectable, do not justify the current high valuation. Recent stock performance shows Laxmi Dental's price has fluctuated, with a current price of 281.40, but it has underperformed the Sensex over the past month, which could reinforce concerns about its valuation. Overall, Laxmi Dental appears to be overvalued in the current market context.

How has been the historical performance of Laxmi Dental?

Laxmi Dental has shown significant growth over the past three years, with net sales increasing from 161.63 Cr in Mar'23 to 239.11 Cr in Mar'25, and profit after tax turning from a loss of 4.45 Cr to a profit of 25.37 Cr. The company's operating profit margin improved from 5.54% to 17.7%, reflecting a strengthening financial position.

Answer:<BR>The historical performance of Laxmi Dental shows significant growth over the past three years, particularly in revenue and profitability.<BR><BR>Breakdown:<BR>Laxmi Dental's net sales have increased from 161.63 Cr in Mar'23 to 239.11 Cr in Mar'25, reflecting a strong upward trend. The total operating income has followed suit, rising from 161.63 Cr in Mar'23 to 239.11 Cr in Mar'25. The company's operating profit (PBDIT) has also seen substantial growth, moving from 11.17 Cr in Mar'23 to 45.21 Cr in Mar'25, with an operating profit margin that improved from 5.54% to 17.7% over the same period. Profit before tax turned positive, reaching 31.83 Cr in Mar'25, compared to a loss of 4.26 Cr in Mar'23, while profit after tax rose from a loss of 4.45 Cr to a profit of 25.37 Cr. The consolidated net profit increased from a loss of 3.97 Cr in Mar'23 to 31.77 Cr in Mar'25. On the balance sheet, total assets grew significantly from 96.38 Cr in Mar'23 to 278.22 Cr in Mar'25, driven by increases in cash and bank balances and total reserves. Total liabilities also rose, but at a slower pace, from 96.38 Cr to 278.22 Cr, indicating a strengthening financial position. Cash flow from operating activities improved dramatically, reaching 43 Cr in Mar'25, compared to only 8 Cr in Mar'24, contributing to a net cash inflow of 125 Cr in Mar'25, a significant turnaround from previous years.

Who are the top shareholders of the Laxmi Dental?

The top shareholders of Laxmi Dental include promoters, with Rajesh Vrajlal Khakhar holding 16.91%, and 27 Foreign Institutional Investors (FIIs) owning 34.24%. The highest public shareholder is Orbimed Asia II Mauritius Limited at 22.41%, while individual investors hold 6.49%.

The top shareholders of Laxmi Dental include a mix of promoters, institutional investors, and public shareholders. The majority shareholders are the promoters, with Rajesh Vrajlal Khakhar holding the highest stake at 16.91%. Among institutional investors, 27 Foreign Institutional Investors (FIIs) collectively hold 34.24%, while 16 mutual fund schemes account for 11.89% of the shares. The highest public shareholder is Orbimed Asia II Mauritius Limited, which holds 22.41%. Additionally, individual investors have a combined holding of 6.49%.

Has Laxmi Dental declared dividend?

No Dividend History Available